Monday, August 24, 2026
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Work with this data → vianewsagency.com
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Press releaseGlobeNewswire· May 21, 2026

Intuitive Announces Innovations to Advance Quintuple Aim

View original at globenewswire.com
Intuitive Announces Innovations to Advance Quintuple Aim SUNNYVALE, Calif., May 21, 2026 (GLOBE NEWSWIRE) -- Intuitive (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced several recent and upcoming innovations, including enhancements across…
Opening lines of the source · GlobeNewswire · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Product quality, safety and reliability are of utmost importance to customers as they increasingly rely on Intuitive's products to serve millions of patients globally.

    60% confidence
  • Intuitive is guided by a commitment to helping customers achieve the Quintuple Aim: improving patient care and outcomes, optimizing surgeon and care team experience, and expanding access to minimally invasive care while lowering the total cost of care.

    60% confidence
  • In 2027, Intuitive anticipates that the number of uses on certain core instruments will again increase, reducing per-procedure costs for da Vinci surgery and supporting the Quintuple Aim.

    60% confidence
  • When da Vinci 5 was introduced with 10,000 times the computing power of Xi, Intuitive committed to enabling the ongoing integration of new functions, capabilities, indications, and instrumentation on a regular cadence.

    60% confidence
  • Instrument encryption enhancements are currently in development and are neither approved/cleared nor available for sale.

    60% confidence
  • Force Feedback is expected to play a central role in advancing augmented dexterity and automated instrument control.

    60% confidence
  • Telepresence enhancements should transform learning and surgeon education around the world to unlock Intuitive's global network of more than 101,000 da Vinci-trained surgeons.

    60% confidence
  • The dV5 Complete Care plan guarantees 98% uptime and is currently exceeding 99% actual uptime.

    60% confidence
  • More than 1,400 da Vinci 5 systems have been installed globally, with more than 380,000 procedures performed by more than 12,800 surgeons in 10 countries as of Q1 2026.

    60% confidence
  • Da Vinci 5 is the most integrated and future-ready platform, designed to continue transforming surgery globally while expanding surgeon autonomy.

    60% confidence

Cited in these Via News reports